Form 4: Heartflow CEO John Farquhar Executes Stock Sale

Heartflow, Inc. CEO John C.M. Farquhar sold 22,562 shares of common stock at $28.50 per share.

Summary

• CEO John C.M. Farquhar sold 22,562 shares of Heartflow, Inc. common stock.
• The transaction occurred on June 10, 2026, at a price of $28.50 per share.
• Following the sale, the CEO retains beneficial ownership of 496,835 shares.
• The sale was executed under a pre-established Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was pre-planned and represents a small portion of the CEO's total holdings.

Positives

• The transaction was conducted via a pre-planned Rule 10b5-1 trading plan, which typically indicates the sale is for personal financial management rather than a reaction to non-public information.

Negatives

• The sale represents a reduction in the CEO's direct equity stake in the company.

Risks

• Insider selling can sometimes be perceived negatively by retail investors as a lack of confidence in future short-term performance.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Management Comments

• The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.

Industry Context

StockSavvy.ai notes that routine insider selling via 10b5-1 plans is a standard practice for executives to diversify personal wealth and is generally viewed as neutral by institutional investors.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives to sell shares while avoiding potential insider trading allegations.

Stakeholder Impact

• Minimal impact expected on shareholders as the sale was pre-planned and executed through a structured trading program.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Heartflow, HTFL, Insider Trading, Form 4, CEO, Equity Sale